Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sabril for Refractory Partial Seizures in Tuberous Sclerosis
NCT01266291Phase 4Terminated
- Sponsor
- University of Pennsylvania
- Start
- Aug 2010
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vigabatrin in focal onset impaired awareness seizure, sponsored by University of Pennsylvania. Started Aug 2010; status: terminated.
02
Drugs
vigabatrin
03
Conditions
focal onset impaired awareness seizure
Beyond the preview
Go deeper on NCT01266291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01266291.